Vascular Endothelial Growth Factor (VEGF) and Soluble VEGF Receptor 1 (sFlt-1) Levels in Early and Mature Human Milk from Mothers of Preterm versus Term Infants
Restricted accessResearch articleFirst published online November, 2012
Vascular Endothelial Growth Factor (VEGF) and Soluble VEGF Receptor 1 (sFlt-1) Levels in Early and Mature Human Milk from Mothers of Preterm versus Term Infants
Vascular endothelial growth factor (VEGF) and its receptors regulate angiogenesis (formation of blood vessels). The soluble VEGF receptor 1 (sFlt-1) binds VEGF as a potent antagonist.
Objective:
The objective of this study was to compare VEGF and sFlt-1 levels in milk from mothers of preterm (n = 50) versus term (n = 49) infants in a longitudinal study.
Methods:
Milk samples were collected on days 3 and 28 of lactation. Vascular endothelial growth factor and sFlt-1 were quantified by sandwich-type enzyme-linked immunosorbent assay.
Results:
Vascular endothelial growth factor and sFlt-1 were found in high concentrations in early milk (lactation day 3) from mothers of preterm and term infants and were lower in mature milk (lactation day 28). On day 3, median VEGF concentration was lower in preterm than in term milk (37.1 vs 53.9 ng/mL, P < .01). Otherwise, VEGF (day 28) and sFlt-1 (days 3 and 28) did not differ in preterm versus term milk.
Conclusions:
It was shown for the first time that sFlt-1 is present in human milk. Early human milk contains high concentrations of VEGF and sFlt-1, which decrease over the course of lactation.
KobataRTsukaharaHOhshimaY. High levels of growth factors in human breast milk. Early Hum Dev. 2008;84:67-69.
2.
SavinoFLiguoriSA. Update of breast milk hormones: leptin, ghrelin and adiponectin. Clin Nutr. 2008;27:42-47.
3.
LucasAMorleyRCleTJListerGLeeson-PayneC. Breast milk and subsequent intelligence quotient in children born preterm. Lancet. 1992;339:261-264.
4.
SembaRDJuulSE. Erythropoietin in human milk: physiology and role in infant health. J Human Lact. 2002;18:252-261.
5.
MilsomSRBlumWFGunnAJ. Temporal changes in insulin-like growth factors I and II and in insulin-like growth factor binding proteins 1, 2, and 3 in human milk. Horm Res. 2008;69:307-311.
6.
OslisloACzubaZSlawskaHKazmierczakWKrolW. Decreased human milk concentration of epidermal growth factor after preterm delivery of intrauterine growth-restricted newborns. J Pediatr Gastroenterol Nutr. 2007;44:464-467.
7.
SiafakasCGAnatolitouFFusunyanRDWalkerWASandersonIR. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res. 1999;45:652-657.
8.
KanERobertsGAndersonPJDoyleLW; the Victorian Infant Collaborative Study Group. The association of growth impairment with neurodevelopmental outcome at eight years of age in very preterm children. Early Hum Dev. 2008;84:409-416.
9.
VanhaesebrouckPAllegaertKBottuJ. Extremely preterm infants in Belgium study group. The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium. Pediatrics. 2004;114:663-675.
10.
KashyapS. Enteral intake for very low birth weight infants: what should the composition be?Sem Perinatol. 2007;31:74-82.
11.
CorpeleijnWEvan VlietIde Gast-BakkerDH. Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates. J Pediatr Gastroenterol Nutr. 2008;46:184-190.
12.
PlayfordRJHanbyAMGschmeissnerSPeifferLPWrightNAMcGarrityT. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut. 1996;39:262-266.
13.
FerraraNHenzelWJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-858.
14.
CamelietP. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet. 2003;4:710-720.
KendallRLThomasKA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci. 1993;90:10705-10709.
17.
HouckKAFerraraNWinerJCachianesGLiBLeungDW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991;5:1806-1814.
18.
RedmanCWGSargentIL. Placental stress and pre-eclampsia: a revised view. Placenta. 30(Suppl A):S38-42.
19.
ShibuyaM. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Molec Biol. 2006;39:469-478.
20.
HashimotoKOhkuraT. Vascular endothelial growth factor in human milk. Br J Biomed Sci. 2000;57:215-217.
21.
VuorelaPAnderssonSCarpénOYlikorkalaOHalmesmäkiE. Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr. 2000;72:1196-1201.
22.
NishimuraSMaenoNMatsuoK. Human lactiferous mammary gland cells produce vascular endothelial growth factor (VEGF) and express the VEGF receptors, Flt-1 and KDR/ Flk-1. Cytokine. 2002;18:191-198.
23.
OzgurtasTAydinITuranO. Vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-I and platelet-derived growth factor levels in human milk of mothers with term and preterm neonates. Cytokine. 2010;50:192-194.
24.
WeberALouiAJochumFBührerCObladenM. Breast milk from mothers of very low birth weight infants: variability in fat and protein content. Acta Paediatr. 2001;90:772-775.
25.
FentonTR. A new growth chart for preterm babies: Babson and Benda’s chart updated with recent data and a new format. BMC Pediatrics. 2003;3:13-23.
26.
SmithPKKrohnRIHermansonGT. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
SmytheJFoxAFisherNFrithEHarrisALWattSM. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood. Tissue Eng Part C Methods. 2008;14:59-67.
29.
PepperMSBaetensDMandriotaSJ. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn. 2000;218:507-524.
30.
SavvidouMDYuCKHarlandLCHingoraniADNicolaidesKH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol. 2006;195:1668-1673.
31.
ClarkDESmithSKHeY. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59:1540-1548.
32.
RomeroRNienJKEspinozaJ. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop pre-eclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23.
33.
BoutsikouTMalamitsi-PuchnerAEconomouEBoutsikouMPuchnerKPHassiakosD. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev. 2006;82:235-239.
